India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya

Dr. Mansukh Mandaviya, Union Minister for Health and Family Welfare, announced on Thursday that India has tripled its rate of organ donation in the last decade...

Exploring the Advantages of Pharmaceutical Pellets in Drug Delivery Systems

Pharmaceutical pellets are designed to release the medication slowly over a period of time, allowing for a more controlled and sustained release of the drug into the body. This method of delivery is particularly beneficial for medications that req...

Indian Pharma is on the lookout for Regulatory Talent, as Vacancies at the Mid and Senior Levels remains a Challenge

The Indian pharmaceutical industry is now looking for talent in regulatory departments, as vacancies at the mid and senior levels continue to be a challenge. The workforce here is responsible for managing the protocols required to submit newer...

Granules Pharma Completes US FDA Post-Marketing Adverse Drug Experience Inspection with Zero Observations

Granules India Limited, a vertically integrated and rapidly growing Indian pharmaceutical company, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company based in Chantilly, Virginia, USA,....

Zydus Lifesciences Gets USFDA Approval for Generic Rheumatoid Arthritis Treatment Drug

Later this week, Zydus Lifesciences Ltd announced that it has gained final permission from the US Food and Drug Administration to manufacture and market its generic Indomethacin suppositories for moderate to severe rheumatoid arthritis...

Yashoda Medicity, Indirapuram and Draeger India Partners to Establish South Asia's largest Modular ICU Setup

Yashoda Medicity, an upcoming healthcare facility in Indirapuram by Yashoda Foundations, is collaborating with Draeger India, a renowned global provider of medical and safety technology solutions...

Pharma Firms with more than Rs 250 crores Turnover to be Given 6 months to Adopt Good Manufacturing Practices says Official Sources

According to official sources, pharma companies with a turnover of more than Rs 250 crore will have six months to implement Good Manufacturing Practises, while companies with a turnover of less than Rs 250 crore will have twelve months...

Flawless Pharma to Invest USD 100 Million in Buyout of Assets & Patents in Hong Kong and China

Flawless Pharma Private Limited, a research-based integrated pharmaceutical company involved in niche API manufacturing and marketing of pharmaceutical ingredient supplier for leading formulators with services such as APIs, custom pharmaceutical...

Glenmark Pharma, OMRON Healthcare India Partners To Combat Hypertension Ignorance Among Young Adults in India

Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led global pharmaceutical company, has partnered with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring...

Amarin, Lotus Pharma Collaborates to Commercialize Vazkepa in Southeast Asia and South Korea

Amarin Corporation plc, an innovative pharmaceutical company, and Lotus Pharmaceuticals, a global pharmaceutical company, announced a long-term exclusive partnership to distribute and commercialise Vazkepa (icosapent ethyl) in ten countries,...

© 2024 India Pharma Outlook. All Rights Reserved.